-
1
-
-
56749186025
-
Six-year survival and causes of death among stroke patients in Korea
-
Kim HC, Choi DP, Ahn SV, Nam CM, Suh I. Six-year survival and causes of death among stroke patients in Korea. Neuroepidemiology 2009;32:94-100.
-
(2009)
Neuroepidemiology
, vol.32
, pp. 94-100
-
-
Kim, H.C.1
Choi, D.P.2
Ahn, S.V.3
Nam, C.M.4
Suh, I.5
-
2
-
-
51649101163
-
Factors affecting the quality of life after ischemis stroke: Young versus old patients
-
Kim JS, Choi-Kwon S, Kwon SU, Lee HJ, Park KA, Seo YS. Factors affecting the quality of life after ischemis stroke: young versus old patients. J Clin Neurol 2005;1:59-68.
-
(2005)
J Clin Neurol
, vol.1
, pp. 59-68
-
-
Kim, J.S.1
Choi-Kwon, S.2
Kwon, S.U.3
Lee, H.J.4
Park, K.A.5
Seo, Y.S.6
-
4
-
-
60549115271
-
Cost-effectiveness of stroke unit care followed by early supported discharge
-
Saka O, Serra V, Samyshkin Y, McGuire A, Wolfe CC. Cost-effectiveness of stroke unit care followed by early supported discharge. Stroke 2009;40:24-29.
-
(2009)
Stroke
, vol.40
, pp. 24-29
-
-
Saka, O.1
Serra, V.2
Samyshkin, Y.3
McGuire, A.4
Wolfe, C.C.5
-
5
-
-
0033790923
-
Cost-effectiveness of stroke prevention
-
Ebrahim S. Cost-effectiveness of stroke prevention. Br Med Bull 2000;56:557-570.
-
(2000)
Br Med Bull
, vol.56
, pp. 557-570
-
-
Ebrahim, S.1
-
6
-
-
15244364036
-
Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: An economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)
-
Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, et al. Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). Eur J Cardiovasc Prev Rehabil 2005;12:29-36.
-
(2005)
Eur J Cardiovasc Prev Rehabil
, vol.12
, pp. 29-36
-
-
Lindgren, P.1
Buxton, M.2
Kahan, T.3
Poulter, N.R.4
Dahlöf, B.5
Sever, P.S.6
-
7
-
-
21744455933
-
The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: Results from the Study on COgnition and Prognosis in the Elderly
-
Lundkvist J, Ekman M, Kartman B, Carlsson J, Jönsson L, Lithell H. The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly. J Hum Hypertens 2005;19: 569-576.
-
(2005)
J Hum Hypertens
, vol.19
, pp. 569-576
-
-
Lundkvist, J.1
Ekman, M.2
Kartman, B.3
Carlsson, J.4
Jönsson, L.5
Lithell, H.6
-
8
-
-
33749324872
-
The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US
-
Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Pharmacoeconomics 2006;24: 1021-1033.
-
(2006)
Pharmacoeconomics
, vol.24
, pp. 1021-1033
-
-
Sullivan, P.W.1
Arant, T.W.2
Ellis, S.L.3
Ulrich, H.4
-
9
-
-
0036636628
-
Effectiveness and cost-effectiveness of echocardiography and carotid imaging in the management of stroke
-
Meenan RT, Saha S, Chou R, Swarztrauber K, Krages KP, O'Keefee-Rosetti M, et al. Effectiveness and cost-effectiveness of echocardiography and carotid imaging in the management of stroke. Evid Rep Technol Assess (Summ) 2002:1-10.
-
(2002)
Evid Rep Technol Assess (Summ)
, pp. 1-10
-
-
Meenan, R.T.1
Saha, S.2
Chou, R.3
Swarztrauber, K.4
Krages, K.P.5
O'Keefee-Rosetti, M.6
-
10
-
-
34147112705
-
Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack
-
Meenan RT, Saha S, Chou R, Swarztrauber K, Pyle Krages K, O'Keeffe-Rosetti MC, et al. Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack. Med Decis Making 2007;27:161-177.
-
(2007)
Med Decis Making
, vol.27
, pp. 161-177
-
-
Meenan, R.T.1
Saha, S.2
Chou, R.3
Swarztrauber, K.4
Pyle Krages, K.5
O'Keeffe-Rosetti, M.C.6
-
11
-
-
26444503709
-
Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation
-
Wilson RD, Murray PK. Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation. Arch Phys Med Rehabil 2005;86:1941-1948.
-
(2005)
Arch Phys Med Rehabil
, vol.86
, pp. 1941-1948
-
-
Wilson, R.D.1
Murray, P.K.2
-
12
-
-
63849312619
-
Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke
-
Patil CG, Long EF, Lansberg MG. Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke. J Neurosurg 2009; 110:508-513.
-
(2009)
J Neurosurg
, vol.110
, pp. 508-513
-
-
Patil, C.G.1
Long, E.F.2
Lansberg, M.G.3
-
13
-
-
0031946671
-
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group
-
Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marler JR, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 1998;50: 883-890.
-
(1998)
Neurology
, vol.50
, pp. 883-890
-
-
Fagan, S.C.1
Morgenstern, L.B.2
Petitta, A.3
Ward, R.E.4
Tilley, B.C.5
Marler, J.R.6
-
14
-
-
0034798437
-
Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: A Canadian healthcare perspective
-
Sinclair SE, Frighetto L, Loewen PS, Sunderji R, Teal P, Fagan SC, et al. Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective. Pharmacoeconomics 2001;19:927-936.
-
(2001)
Pharmacoeconomics
, vol.19
, pp. 927-936
-
-
Sinclair, S.E.1
Frighetto, L.2
Loewen, P.S.3
Sunderji, R.4
Teal, P.5
Fagan, S.C.6
-
15
-
-
0036217797
-
Development of a decision-analytic model of stroke care in the United States and Europe
-
Chambers MG, Koch P, Hutton J. Development of a decision-analytic model of stroke care in the United States and Europe. Value Health 2002; 5:82-97.
-
(2002)
Value Health
, vol.5
, pp. 82-97
-
-
Chambers, M.G.1
Koch, P.2
Hutton, J.3
-
16
-
-
2542530145
-
Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs
-
Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, et al. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs. Stroke 2004;35:1490-1497.
-
(2004)
Stroke
, vol.35
, pp. 1490-1497
-
-
Sandercock, P.1
Berge, E.2
Dennis, M.3
Forbes, J.4
Hand, P.5
Kwan, J.6
-
17
-
-
0042431628
-
Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations
-
Stahl JE, Furie KL, Gleason S, Gazelle GS. Stroke: effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations. Radiology 2003;228:659-668.
-
(2003)
Radiology
, vol.228
, pp. 659-668
-
-
Stahl, J.E.1
Furie, K.L.2
Gleason, S.3
Gazelle, G.S.4
-
18
-
-
2142643205
-
Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke
-
Moodie ML, Carter R, Mihalopoulos C, Thrift AG, Chambers BR, Donnan GA, et al. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke. Stroke 2004;35:1041-1046.
-
(2004)
Stroke
, vol.35
, pp. 1041-1046
-
-
Moodie, M.L.1
Carter, R.2
Mihalopoulos, C.3
Thrift, A.G.4
Chambers, B.R.5
Donnan, G.A.6
-
19
-
-
24344467365
-
Cost-effectiveness analysis of thrombolytic treatment for stroke
-
Mar J, Begiristain JM, Arrazola A. Cost-effectiveness analysis of thrombolytic treatment for stroke. Cerebrovasc Dis 2005;20:193-200.
-
(2005)
Cerebrovasc Dis
, vol.20
, pp. 193-200
-
-
Mar, J.1
Begiristain, J.M.2
Arrazola, A.3
-
20
-
-
33845918908
-
Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke
-
Ehlers L, Andersen G, Clausen LB, Bech M, Kjolby M. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke. Stroke 2007;38:85-89.
-
(2007)
Stroke
, vol.38
, pp. 85-89
-
-
Ehlers, L.1
Andersen, G.2
Clausen, L.B.3
Bech, M.4
Kjolby, M.5
-
21
-
-
0032519289
-
Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: An assessment of currently available literature
-
Wade WE. Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literature. Thromb Res 1998;89:199-202.
-
(1998)
Thromb Res
, vol.89
, pp. 199-202
-
-
Wade, W.E.1
-
22
-
-
0034626359
-
Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack
-
Sarasin FP, Gaspoz JM, Bounameaux H. Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack. Arch Intern Med 2000;160:2773-2778.
-
(2000)
Arch Intern Med
, vol.160
, pp. 2773-2778
-
-
Sarasin, F.P.1
Gaspoz, J.M.2
Bounameaux, H.3
-
23
-
-
27744576942
-
Cost-effectiveness of antiplatelet agents in secondary stroke prevention: The limits of certainty
-
Matchar DB, Samsa GP, Liu S. Cost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certainty. Value He-alth 2005;8:572-580.
-
(2005)
Value He-alth
, vol.8
, pp. 572-580
-
-
Matchar, D.B.1
Samsa, G.P.2
Liu, S.3
-
24
-
-
0034003929
-
Aspirin plus extended-release dipyridamole or clopidogrel compared with aspirin monotherapy for the prevention of recurrent ischemic stroke: A cost-effectiveness analysis
-
Shah H, Gondek K. Aspirin plus extended-release dipyridamole or clopidogrel compared with aspirin monotherapy for the prevention of recurrent ischemic stroke: a cost-effectiveness analysis. Clin Ther 2000; 22:362-370.
-
(2000)
Clin Ther
, vol.22
, pp. 362-370
-
-
Shah, H.1
Gondek, K.2
-
26
-
-
0029957548
-
Rehabilitation after stroke: Cost-effectiveness analyses
-
Keith RA. Rehabilitation after stroke: cost-effectiveness analyses. J R Soc Med 1996;89:631-633.
-
(1996)
J R Soc Med
, vol.89
, pp. 631-633
-
-
Keith, R.A.1
-
27
-
-
20444377250
-
Cost-effectiveness of integrated stroke services
-
van Exel NJ, Koopmanschap MA, Scholteop Reimer W, Niessen LW, Huijsman R. Cost-effectiveness of integrated stroke services. QJM 2005;98:415-425.
-
(2005)
QJM
, vol.98
, pp. 415-425
-
-
van Exel, N.J.1
Koopmanschap, M.A.2
Scholteop Reimer, W.3
Niessen, L.W.4
Huijsman, R.5
-
28
-
-
1442299258
-
Estimating the cost-effectiveness of stroke units in France compared with conventional care
-
Launois R, Giroud M, Mégnigbêto AC, Le Lay K, Présenté G, Mahagne MH, et al. Estimating the cost-effectiveness of stroke units in France compared with conventional care. Stroke 2004;35:770-775.
-
(2004)
Stroke
, vol.35
, pp. 770-775
-
-
Launois, R.1
Giroud, M.2
Mégnigbêto, A.C.3
Le Lay, K.4
Présenté, G.5
Mahagne, M.H.6
-
29
-
-
34247844511
-
The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
-
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups
-
Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-1711.
-
(2007)
Stroke
, vol.38
, pp. 1655-1711
-
-
Adams Jr., H.P.1
del Zoppo, G.2
Alberts, M.J.3
Bhatt, D.L.4
Brass, L.5
Furlan, A.6
-
31
-
-
0033057012
-
A systematic review of cost-effectiveness research of stroke evaluation and treatment
-
Holloway RG, Benesch CG, Rahilly CR, Courtright CE. A systematic review of cost-effectiveness research of stroke evaluation and treatment. Stroke 1999;30:1340-1349.
-
(1999)
Stroke
, vol.30
, pp. 1340-1349
-
-
Holloway, R.G.1
Benesch, C.G.2
Rahilly, C.R.3
Courtright, C.E.4
-
32
-
-
5344243751
-
Cost-effectiveness analysis of tissue plasminogen activator for acute ischemic stroke: A comparative review
-
Tseng MC, Chang KC. Cost-effectiveness analysis of tissue plasminogen activator for acute ischemic stroke: a comparative review. Acta Neurol Taiwan 2004;13:149-155.
-
(2004)
Acta Neurol Taiwan
, vol.13
, pp. 149-155
-
-
Tseng, M.C.1
Chang, K.C.2
-
33
-
-
84903867482
-
-
Korean Exchange Bank. [cited]; Available from
-
Korean Exchange Bank. [cited]; Available from: http://inflationdata.com/.
-
-
-
-
34
-
-
84903875592
-
-
Inflationdata.com. [cited]; Available from
-
Inflationdata.com. [cited]; Available from: http://inflationdata.com/.
-
-
-
-
35
-
-
0030840642
-
Modelling in economic evaluation: An unavoidable fact of life
-
Buxton MJ, Drummond MF, Van Hout BA, Prince RL, Sheldon TA, Szucs T, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997;6:217-227.
-
(1997)
Health Econ
, vol.6
, pp. 217-227
-
-
Buxton, M.J.1
Drummond, M.F.2
Van Hout, B.A.3
Prince, R.L.4
Sheldon, T.A.5
Szucs, T.6
-
36
-
-
39749111776
-
Impact of functional status at six months on long term survival in patients with ischaemic stroke: Prospective cohort studies
-
Oxfordshire Community Stroke Project, the International Stroke Trial (UK): Lothian Stroke Register
-
Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P; Oxfordshire Community Stroke Project, the International Stroke Trial (UK): Lothian Stroke Register. Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ 2008;336:376-379.
-
(2008)
BMJ
, vol.336
, pp. 376-379
-
-
Slot, K.B.1
Berge, E.2
Dorman, P.3
Lewis, S.4
Dennis, M.5
Sandercock, P.6
-
37
-
-
44449156444
-
Functional outcome 3 months after stroke predicts long-term survival
-
Eriksson M, Norrving B, Terént A, Stegmayr B. Functional outcome 3 months after stroke predicts long-term survival. Cerebrovasc Dis 2008; 25:423-429.
-
(2008)
Cerebrovasc Dis
, vol.25
, pp. 423-429
-
-
Eriksson, M.1
Norrving, B.2
Terént, A.3
Stegmayr, B.4
-
38
-
-
0032541845
-
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (EC-ASS II). Second European-Australasian Acute Stroke Study Investigators
-
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (EC-ASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.
-
(1998)
Lancet
, vol.352
, pp. 1245-1251
-
-
Hacke, W.1
Kaste, M.2
Fieschi, C.3
von Kummer, R.4
Davalos, A.5
Meier, D.6
-
39
-
-
34247887746
-
Promoting Acute Thrombolysis for Ischaemic Stroke (PRACTISE)
-
Dirks M, Niessen LW, Huijsman R, van Wijngaarden J, Minkman MM, Franke CL, et al. Promoting Acute Thrombolysis for Ischaemic Stroke (PRACTISE). Int J Stroke 2007;2:151-159.
-
(2007)
Int J Stroke
, vol.2
, pp. 151-159
-
-
Dirks, M.1
Niessen, L.W.2
Huijsman, R.3
van Wijngaarden, J.4
Minkman, M.M.5
Franke, C.L.6
-
40
-
-
70449601229
-
Are in-Hospital Delays Important Obstacles In Thrombolytic Therapy Following Acute Ischemic Stroke?
-
Choi JC, Kang SY, Kang JH, Ko YJ, Bae JM. Are in-Hospital Delays Important Obstacles In Thrombolytic Therapy Following Acute Ischemic Stroke? J Clin Neurol 2007;3:71-78.
-
(2007)
J Clin Neurol
, vol.3
, pp. 71-78
-
-
Choi, J.C.1
Kang, S.Y.2
Kang, J.H.3
Ko, Y.J.4
Bae, J.M.5
-
41
-
-
77953356688
-
Multimodal MRI for ischemic stroke: From acute therapy to preventive strategies
-
Bang OY. Multimodal MRI for ischemic stroke: from acute therapy to preventive strategies. J Clin Neurol 2009;5:107-119.
-
(2009)
J Clin Neurol
, vol.5
, pp. 107-119
-
-
Bang, O.Y.1
-
42
-
-
18844477380
-
Recommendations for the establishment of primary stroke centers. Brain Attack Coalition
-
Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000;283:3102-3109.
-
(2000)
JAMA
, vol.283
, pp. 3102-3109
-
-
Alberts, M.J.1
Hademenos, G.2
Latchaw, R.E.3
Jagoda, A.4
Marler, J.R.5
Mayberg, M.R.6
-
43
-
-
22044445060
-
Recommendations for comprehensive stroke centers: A consensus statement from the Brain Attack Coalition
-
Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36: 1597-1616.
-
(2005)
Stroke
, vol.36
, pp. 1597-1616
-
-
Alberts, M.J.1
Latchaw, R.E.2
Selman, W.R.3
Shephard, T.4
Hadley, M.N.5
Brass, L.M.6
|